Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Institute for Drug Research,
School of Pharmacy,
Institute for Drug Research, School of Pharmacy
Ofra Benny has not added Biography.
If you are Ofra Benny and would like to personalize this page please email our Author Liaison for assistance.
A fail-safe mechanism for negative selection of isotype-switched B cell precursors is regulated by the Fas/FasL pathway.
The Journal of experimental medicine Nov, 2003 | Pubmed ID: 14623914
Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2005 | Pubmed ID: 15701867
Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.
Biopolymers Apr 5-15, 2007 | Pubmed ID: 17266128
Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth.
Molecular cancer therapeutics Aug, 2007 | Pubmed ID: 17699732
Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Feb, 2008 | Pubmed ID: 17873101
In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Feb, 2008 | Pubmed ID: 17873103
Dendritic cells augment choroidal neovascularization.
Investigative ophthalmology & visual science Aug, 2008 | Pubmed ID: 18408184
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.
Nature biotechnology Jul, 2008 | Pubmed ID: 18587385
Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Oct, 2008 | Pubmed ID: 18606869
Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2009 | Pubmed ID: 19190128
Novel technologies for antiangiogenic drug delivery in the brain.
Cell adhesion & migration Apr-Jun, 2009 | Pubmed ID: 19262168
Alginate-PLL cell encapsulation system Co-entrapping PLGA-microspheres for the continuous release of anti-inflammatory drugs.
Biomedical microdevices Oct, 2009 | Pubmed ID: 19517239
Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes.
Anticancer research Apr, 2010 | Pubmed ID: 20530409
Broad spectrum antiangiogenic treatment for ocular neovascular diseases.
PloS one , 2010 | Pubmed ID: 20824139
Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.
The American journal of pathology Apr, 2011 | Pubmed ID: 21435458
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.
The Journal of clinical investigation Jan, 2012 | Pubmed ID: 22182838
The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action.
Angiogenesis Apr, 2013 | Pubmed ID: 23150059
Suppression of autoimmune retinal inflammation by an antiangiogenic drug.
PloS one , 2013 | Pubmed ID: 23785488
Epoxyeicosanoids promote organ and tissue regeneration.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2013 | Pubmed ID: 23898174
Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment.
The Journal of clinical investigation Jan, 2014 | Pubmed ID: 24355922
Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity.
The Journal of pharmacology and experimental therapeutics Sep, 2014 | Pubmed ID: 24939421
The Hebrew University of Jerusalem
Amy E. Birsner*,1,
Ofra Benny*,2,
Robert J. D'Amato1,3
1Vascular Biology Program, Boston Children's Hospital,
2Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem,
3Department of Ophthalmology, Harvard Medical School
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.